Finance

Beta
Lists
506943:BOM
J B Chemicals and Pharmaceuticals Ltd
₹2,130.40
-0.43%
(-9.10) 1D
Jun 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506943...
Open
₹2,136.05
High
₹2,162.30
Low
₹2,123.60
Mkt. cap
342.99B
Avg. vol.
17.80K
Volume
10.65K
Dividend
1.03%
Quarterly dividend
₹5.50
Ex-dividend date
May 29, 2026
P/E ratio
47.93
52-wk high
₹2,284.95
52-wk low
₹1,603.05
EPS
₹44.45
Shares outstanding
80.24M
No. of employees
6K
Open
₹2,136.05
High
₹2,162.30
Low
₹2,123.60
Mkt. cap
342.99B
Avg. vol.
17.80K
Volume
10.65K
Dividend
1.03%
Quarterly dividend
₹5.50
Ex-dividend date
May 29, 2026
P/E ratio
47.93
52-wk high
₹2,284.95
52-wk low
₹1,603.05
EPS
₹44.45
Shares outstanding
80.24M
No. of employees
6K
News stories
From sources across the web
About J B Chemicals and Pharmaceuticals Ltd
CEONikhil Chopra
Employees5.6K
Founded1976
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.94B
10.85B
10.65B
9.04B
Cost of goods sold
3.47B
3.45B
3.29B
3.15B
Cost of revenue
3.47B
3.45B
3.29B
3.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.94B
1.88B
1.91B
4.69B
Operating expense
4.89B
4.74B
4.85B
4.40B
Total operating expenses
8.36B
8.20B
8.14B
7.55B
Operating income
2.58B
2.65B
2.50B
1.49B
Other non operating income
145.50M
153.40M
182.80M
-476.47M
EBT including unusual items
2.72B
2.79B
2.67B
1.35B
EBT excluding unusual items
2.72B
2.79B
2.67B
1.36B
Income tax expense
692.30M
713.30M
689.80M
333.22M
Effective tax rate
25.49%
25.55%
25.85%
24.74%
Other operating expenses
2.52B
2.42B
2.48B
-784.57M
Net income
2.02B
2.08B
1.98B
1.01B
Net profit margin
18.50%
19.16%
18.59%
11.21%
Earnings per share
12.75
13.08
12.45
7.60
Interest and investment income
-
-
-
337.48M
Interest expense
-11.10M
-13.50M
-18.80M
-6.36M
Net interest expenses
-11.10M
-13.50M
-18.80M
331.12M
Depreciation and amortization charges
427.00M
444.40M
453.50M
500.09M
EBITDA
2.98B
3.09B
2.90B
1.91B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more